These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 32630312)
1. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation. Chen MC; Hsu LL; Wang SF; Hsu CY; Lee HC; Tseng LM Cells; 2020 Jul; 9(7):. PubMed ID: 32630312 [TBL] [Abstract][Full Text] [Related]
2. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. Koppula P; Zhang Y; Shi J; Li W; Gan B J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042 [TBL] [Abstract][Full Text] [Related]
3. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress. Habib E; Linher-Melville K; Lin HX; Singh G Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424 [TBL] [Abstract][Full Text] [Related]
4. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose. Joly JH; Delfarah A; Phung PS; Parrish S; Graham NA J Biol Chem; 2020 Jan; 295(5):1350-1365. PubMed ID: 31914417 [TBL] [Abstract][Full Text] [Related]
5. Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury. Meyer AR; Engevik AC; Willet SG; Williams JA; Zou Y; Massion PP; Mills JC; Choi E; Goldenring JR Cell Mol Gastroenterol Hepatol; 2019; 8(3):379-405. PubMed ID: 31071489 [TBL] [Abstract][Full Text] [Related]
6. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma. Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923 [TBL] [Abstract][Full Text] [Related]
7. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11). Yamaguchi I; Yoshimura SH; Katoh H J Biol Chem; 2020 May; 295(20):6936-6945. PubMed ID: 32265299 [TBL] [Abstract][Full Text] [Related]
8. Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells. Lee Y; Itahana Y; Ong CC; Itahana K J Cell Sci; 2022 Aug; 135(15):. PubMed ID: 35775474 [TBL] [Abstract][Full Text] [Related]
9. Cystine-glutamate antiporter xCT as a therapeutic target for cancer. Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001 [TBL] [Abstract][Full Text] [Related]
10. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain. Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686 [TBL] [Abstract][Full Text] [Related]
11. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy. Otsuki Y; Yamasaki J; Suina K; Okazaki S; Koike N; Saya H; Nagano O Cancer Sci; 2020 Jan; 111(1):127-136. PubMed ID: 31692172 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor promotes glioblastoma cell death under glucose deprivation via upregulation of xCT (SLC7A11). Yamamoto M; Teramoto K; Katoh H Cell Signal; 2021 Feb; 78():109874. PubMed ID: 33285240 [TBL] [Abstract][Full Text] [Related]
13. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Koppula P; Zhuang L; Gan B Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412 [TBL] [Abstract][Full Text] [Related]
14. IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC-. Yang Y; Yee D Cancer Res; 2014 Apr; 74(8):2295-305. PubMed ID: 24686172 [TBL] [Abstract][Full Text] [Related]
15. Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition. Ye P; Mimura J; Okada T; Sato H; Liu T; Maruyama A; Ohyama C; Itoh K Mol Cell Biol; 2014 Sep; 34(18):3421-34. PubMed ID: 25002527 [TBL] [Abstract][Full Text] [Related]
16. Salubrinal Enhances Cancer Cell Death during Glucose Deprivation through the Upregulation of xCT and Mitochondrial Oxidative Stress. Chen MC; Hsu LL; Wang SF; Pan YL; Lo JF; Yeh TS; Tseng LM; Lee HC Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572286 [TBL] [Abstract][Full Text] [Related]
17. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway. Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640 [TBL] [Abstract][Full Text] [Related]
18. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Shin CS; Mishra P; Watrous JD; Carelli V; D'Aurelio M; Jain M; Chan DC Nat Commun; 2017 Apr; 8():15074. PubMed ID: 28429737 [TBL] [Abstract][Full Text] [Related]
19. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells. Linher-Melville K; Haftchenary S; Gunning P; Singh G Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132 [TBL] [Abstract][Full Text] [Related]
20. Activated Integrated Stress Response Induced by Salubrinal Promotes Cisplatin Resistance in Human Gastric Cancer Cells via Enhanced xCT Expression and Glutathione Biosynthesis. Wang SF; Wung CH; Chen MS; Chen CF; Yin PH; Yeh TS; Chang YL; Chou YC; Hung HH; Lee HC Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]